182 related articles for article (PubMed ID: 9520015)
1. Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumor.
de la Sayette V; Bertran F; Honnorat J; Schaeffer S; Iglesias S; Defer G
Arch Neurol; 1998 Mar; 55(3):405-8. PubMed ID: 9520015
[TBL] [Abstract][Full Text] [Related]
2. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.
Honnorat J; Antoine JC; Derrington E; Aguera M; Belin MF
J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):270-8. PubMed ID: 8795598
[TBL] [Abstract][Full Text] [Related]
4. POP66, a paraneoplastic encephalomyelitis-related antigen, is a marker of adult oligodendrocytes.
Honnorat J; Aguera M; Zalc B; Goujet C; Quach T; Antoine JC; Belin MF
J Neuropathol Exp Neurol; 1998 Apr; 57(4):311-22. PubMed ID: 9600223
[TBL] [Abstract][Full Text] [Related]
5. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic optic neuritis and encephalomyelitis. Report of a case.
Boghen D; Sebag M; Michaud J
Arch Neurol; 1988 Mar; 45(3):353-6. PubMed ID: 3341961
[TBL] [Abstract][Full Text] [Related]
7. [Paraneoplastic optic neuritis in an unknown small cell lung carcinoma defined by CRMP-5-IgG].
Toribio-García JA; Franco-Benito M; García-Ruiz-de-Morales JM
Arch Soc Esp Oftalmol; 2007 Dec; 82(12):777-80. PubMed ID: 18040924
[TBL] [Abstract][Full Text] [Related]
8. CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.
Nakajima M; Uchibori A; Ogawa Y; Miyazaki T; Ichikawa Y; Kaneko K; Takahashi T; Nakashima I; Shiraishi H; Motomura M; Chiba A
Intern Med; 2018 Jun; 57(11):1645-1649. PubMed ID: 29321433
[TBL] [Abstract][Full Text] [Related]
9. Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies.
Arés-Luque A; García-Tuñón LA; Saiz A; Cabezas BC; Hernández-Echebarría LE; Franco M; Toribio A; Tejada J; Graus F
J Neurol; 2007 Aug; 254(8):1131-2. PubMed ID: 17401741
[No Abstract] [Full Text] [Related]
10. [Amyotrophic lateral sclerosis and anti-CV2 antibodies. Paraneoplastic association?].
García Martín G; Perez Errazquin F; Chamorro Muñoz M; Romero Acebal M
Neurologia; 2007; 22(6):406-9. PubMed ID: 17610172
[TBL] [Abstract][Full Text] [Related]
11. Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.
Song J; Zhang Y; Lang Y; Wang YH; Shao J; Cui L
BMC Neurol; 2021 Oct; 21(1):408. PubMed ID: 34702214
[TBL] [Abstract][Full Text] [Related]
12. Small cell lung cancer and progressive retinopathy.
Morita M; Fukuhara T; Takahashi H; Maemondo M
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25422332
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG.
Cross SA; Salomao DR; Parisi JE; Kryzer TJ; Bradley EA; Mines JA; Lam BL; Lennon VA
Ann Neurol; 2003 Jul; 54(1):38-50. PubMed ID: 12838519
[TBL] [Abstract][Full Text] [Related]
14. Distinct clinical characteristics of paraneoplastic optic neuropathy.
Xu Q; Du W; Zhou H; Zhang X; Liu H; Song H; Wang X; Wei S
Br J Ophthalmol; 2019 Jun; 103(6):797-801. PubMed ID: 30021813
[TBL] [Abstract][Full Text] [Related]
15. [Paraneoplastic ataxia associated to anti CV2 antibodies].
Medrano V; Sempere AP; González E
Rev Neurol; 2003 Jan 16-31; 36(2):131-3. PubMed ID: 12589599
[TBL] [Abstract][Full Text] [Related]
16. Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors.
Antoine JC; Absi L; Honnorat J; Boulesteix JM; de Brouker T; Vial C; Butler M; De Camilli P; Michel D
Arch Neurol; 1999 Feb; 56(2):172-7. PubMed ID: 10025422
[TBL] [Abstract][Full Text] [Related]
17. Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration.
Greenlee JE; Lipton HL
Ann Neurol; 1986 Jan; 19(1):82-5. PubMed ID: 3004320
[TBL] [Abstract][Full Text] [Related]
18. Are the "newly discovered" paraneoplastic anticollapsin response-mediator protein 5 antibodies simply anti-CV2 antibodies?
Honnorat J; Antoine JC; Belin MF
Ann Neurol; 2001 Nov; 50(5):688-91. PubMed ID: 11706981
[No Abstract] [Full Text] [Related]
19. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration.
Anderson NE; Budde-Steffen C; Wiley RG; Thurman L; Rosenblum MK; Nadeau SE; Posner JB
Neurology; 1988 Jul; 38(7):1018-26. PubMed ID: 3290700
[TBL] [Abstract][Full Text] [Related]
20. Anti-Ri-associated paraneoplastic cerebellar and brainstem degenerative syndrome.
Tay JK; Miller J; Joshi A; Athey RJ
J R Coll Physicians Edinb; 2012; 42(3):221-4. PubMed ID: 22953316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]